Immucor Gets Formal SEC Order
The order relates to a probe of payments the company's Italian unit made.
Immucor
(BLUD)
said the
Securities and Exchange Commission
issued a formal order as part of its investigation of payments the company's Italian unit made to people associated with government medical facilities in Italy.
The formal order allows the staff of the SEC to mandate testimony and require the company to turn over documents. The investigation began after the Norcross, Ga., company told the SEC about a violation of the requirements of the Foreign Corrupt Practices Act.
Immucor, which sells reagents and systems used to identify the properties of blood prior to a transfusion, said it will continue to cooperate with the SEC.
Shares of Immucor were down 90 cents, or 3%, to $27.71.
